罗欣药业
(002793)
| 流通市值：50.17亿 | | | 总市值：50.25亿 |
| 流通股本：10.86亿 | | | 总股本：10.88亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 410,737,025.84 | 456,677,239.94 | 682,812,040.73 | 898,312,952.49 |
| 应收票据及应收账款 | 416,191,421.95 | 569,106,113.41 | 464,946,941.39 | 445,937,122.41 |
| 应收账款 | 416,191,421.95 | 569,106,113.41 | 464,946,941.39 | 445,937,122.41 |
| 应收款项融资 | 43,730,343.3 | 32,464,517.45 | 10,955,682.2 | 34,642,641.66 |
| 预付款项 | 76,272,295.99 | 70,305,378.69 | 106,552,263.4 | 166,960,057.25 |
| 其他应收款合计 | 56,808,509.95 | 61,363,581.29 | 104,217,674.39 | 105,491,479.93 |
| 存货 | 458,909,704.78 | 459,555,606.49 | 535,298,326.98 | 522,796,634.8 |
| 一年内到期的非流动资产 | 87,892,000 | 87,897,627.96 | 82,992,000 | 82,992,000 |
| 其他流动资产 | 44,344,610.13 | 45,759,535.39 | 53,837,856.1 | 67,789,763.05 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,600,136,248.16 | 1,784,379,936.84 | 2,043,712,785.19 | 2,348,157,159.16 |
| 非流动资产: | | | | |
| 长期应收款 | 45,014,347.47 | 45,014,347.47 | 45,014,347.47 | 45,014,347.47 |
| 长期股权投资 | 177,976,465.41 | 182,690,194.67 | 172,186,361.26 | 177,857,786.59 |
| 其他权益工具投资 | 60,426,243.02 | 60,426,243.02 | 60,839,905.03 | 61,876,564.09 |
| 其他非流动金融资产 | - | - | 1,250,336.22 | - |
| 投资性房地产 | 11,641,949.26 | 11,857,344.64 | - | - |
| 固定资产 | 1,199,091,616.61 | 1,236,427,913.24 | 1,436,116,227.6 | 1,168,842,746.59 |
| 在建工程 | 24,915,072.33 | 20,428,299.46 | 44,859,687.81 | 363,209,813.25 |
| 使用权资产 | 36,781,065.17 | 39,620,196.2 | 37,711,096.21 | 39,316,196.91 |
| 无形资产 | 486,339,006.75 | 487,366,064.32 | 470,508,653.75 | 457,031,892.4 |
| 开发支出 | 188,679,990.01 | 187,030,765.6 | 256,741,195.4 | 250,340,728.25 |
| 商誉 | 1,953,023.99 | 1,953,023.99 | 1,953,023.99 | 1,953,023.99 |
| 长期待摊费用 | 16,304,980.66 | 17,584,123.23 | 16,879,602.7 | 18,419,291 |
| 递延所得税资产 | 173,735,507.63 | 188,390,646.67 | 261,466,371.01 | 279,262,103.47 |
| 其他非流动资产 | 62,633,831.21 | 72,809,162.4 | 40,037,713.2 | 42,285,204.52 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,485,493,099.52 | 2,551,598,324.91 | 2,845,564,521.65 | 2,905,409,698.53 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,085,629,347.68 | 4,335,978,261.75 | 4,889,277,306.84 | 5,253,566,857.69 |
| 流动负债: | | | | |
| 短期借款 | 706,384,546.88 | 742,078,810.48 | 946,486,153.68 | 1,072,884,764.28 |
| 交易性金融负债 | 217,177,806.08 | 217,177,806.08 | 4,046,892.28 | 4,046,892.28 |
| 应付票据及应付账款 | 571,757,704.88 | 544,097,071.07 | 456,283,094.43 | 469,023,143.96 |
| 其中：应付票据 | 111,395,773.07 | 82,801,606.44 | 7,304,868 | - |
| 应付账款 | 460,361,931.81 | 461,295,464.63 | 448,978,226.43 | 469,023,143.96 |
| 合同负债 | 80,759,618.85 | 66,041,489.95 | 86,056,047.64 | 107,958,210.69 |
| 应付职工薪酬 | 84,711,779.91 | 107,666,014.08 | 57,961,910.18 | 51,281,924.62 |
| 应交税费 | 12,465,827.94 | 39,019,833.37 | 13,322,634.41 | 13,247,583.57 |
| 其他应付款合计 | 112,566,833.44 | 154,097,372.78 | 98,845,283.8 | 107,500,435.77 |
| 应付股利 | 1,270,308.27 | 1,270,308.27 | 1,270,308.27 | 1,270,308.27 |
| 一年内到期的非流动负债 | 404,543,652.75 | 662,218,380.69 | 734,268,647.43 | 726,575,620.51 |
| 其他流动负债 | 7,968,595.69 | 5,588,103.5 | 9,562,286.19 | 11,920,063.76 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,198,336,366.42 | 2,537,984,882 | 2,406,832,950.04 | 2,571,102,955.88 |
| 非流动负债: | | | | |
| 长期借款 | 229,387,599.59 | 133,384,266.26 | 171,786,862.39 | 171,037,146.75 |
| 租赁负债 | 31,231,026.64 | 33,685,030.66 | 32,771,470.9 | 33,131,124.99 |
| 长期应付款 | 57,183,457.23 | 68,950,852.81 | - | - |
| 预计负债 | 14,970,017.36 | 16,291,363.79 | 35,840,938.94 | 34,708,100.12 |
| 递延收益 | 75,749,337.8 | 78,920,081.77 | 81,790,825.74 | 84,560,526.26 |
| 递延所得税负债 | 6,977,471.28 | 7,357,531.22 | 6,212,088.32 | 6,797,559.63 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 415,498,909.9 | 338,589,126.51 | 328,402,186.29 | 330,234,457.75 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,613,835,276.32 | 2,876,574,008.51 | 2,735,235,136.33 | 2,901,337,413.63 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,087,588,486 | 1,087,588,486 | 1,087,588,486 | 1,087,588,486 |
| 资本公积 | 387,245,155.57 | 380,184,963.69 | 472,366,560.81 | 472,615,899.61 |
| 减:库存股 | 29,999,578.53 | 29,999,578.53 | 99,998,598.94 | 99,998,598.94 |
| 其他综合收益 | 21,894,171.85 | 21,947,786.2 | 21,485,941.53 | 23,459,734.03 |
| 盈余公积 | 12,836,903.17 | 12,836,903.17 | 12,836,903.17 | 12,836,903.17 |
| 未分配利润 | -84,630,131.32 | -90,281,280.82 | 609,844,393.66 | 786,504,934.7 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,394,935,006.74 | 1,382,277,279.71 | 2,104,123,686.23 | 2,283,007,358.57 |
| 少数股东权益 | 76,859,064.62 | 77,126,973.53 | 49,918,484.28 | 69,222,085.49 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,471,794,071.36 | 1,459,404,253.24 | 2,154,042,170.51 | 2,352,229,444.06 |
| 负债和股东权益合计 | 4,085,629,347.68 | 4,335,978,261.75 | 4,889,277,306.84 | 5,253,566,857.69 |
| 公告日期 | 2025-04-22 | 2025-04-22 | 2024-10-30 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |